Skip to main content
Fig. 1 | Biomarker Research

Fig. 1

From: Usefulness of procalcitonin at admission as a risk-stratifying biomarker for 50-day in-hospital mortality among patients with community-acquired bloodstream infection: an observational cohort study

Fig. 1

A 50-day in-hospital mortality rate in the whole cohort and according to baseline plasma procalcitonin threshold defined in receiver operating characteristic (ROC) analysis (> 4.24 ng/mL); B 50-day in-hospital mortality rate according to baseline plasma procalcitonin quartiles

Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us